Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2

被引：3
|
作者：
Temel, Jennifer S.
Currow, David Christopher
Fearon, Kenneth
Yan, Ying
Friend, John
Abernethy, Amy Pickar
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Helsinn Therapeut Inc, Iselin, NJ USA
[5] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 29期
关键词：
D O I：
10.1200/jco.2015.33.29_suppl.175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2)
    Temel, Jennifer S.
    Currow, David Christopher
    Fearon, Kenneth
    Yan, Ying
    Friend, John
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Anamorelin Efficacy in Non-Small-Cell Lung Cancer Patients With Cachexia: Insights From ROMANA 1 and ROMANA 2
    Laird, Barry J. A.
    Skipworth, Richard
    Bonomi, Philip D.
    Fallon, Marie
    Kaasa, Stein
    Giorgino, Ruben
    Mcmillan, Donald C.
    Currow, David C.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
  • [3] EVALUATION OF ANOREXIA-CACHEXIA SYMPTOMS/CONCERNS FROM ROMANA 2, A PHASE III TRIAL OF ANAMORELIN IN NON-SMALL CELL LUNG CANCER PATIENTS WITH CACHEXIA.
    Brewer, Cheryl
    Abernethy, Amy
    Currow, David
    Fearon, Kenneth
    Friend, John
    Temel, Jennifer
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E229 - E229
  • [4] ROMANA 3: A safety extension study of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with cachexia
    Currow, D.
    Temel, J.
    Fearon, K.
    Friend, J.
    Yan, Y.
    Abernethy, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S239 - S239
  • [5] A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3.
    Currow, David Christopher
    Temel, Jennifer S.
    Fearon, Kenneth
    Yan, Ying
    Friend, John
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
    Temel, Jennifer S.
    Abernethy, Amy P.
    Currow, David C.
    Friend, John
    Duus, Elizabeth M.
    Yan, Ying
    Fearon, Kenneth C.
    LANCET ONCOLOGY, 2016, 17 (04): : 519 - 531
  • [7] ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
    Currow, D.
    Temel, J. S.
    Abernethy, A.
    Milanowski, J.
    Friend, J.
    Fearon, K. C.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1949 - 1956
  • [8] ONO-7643/anamorelin for the treatment of patients with non-small cell lung cancer and cachexia: results from phase 2 study with Japanese patients
    Uchino, J.
    Katakami, N.
    Yokoyama, T.
    Naito, T.
    Kondo, M.
    Yamada, K.
    Kitajima, H.
    Yoshimori, K.
    Sato, K.
    Takiguchi, Y.
    Takayama, K.
    Eguchi, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
    Koichi Takayama
    Nobuyuki Katakami
    Takuma Yokoyama
    Shinji Atagi
    Kozo Yoshimori
    Hiroshi Kagamu
    Hiroshi Saito
    Yuichi Takiguchi
    Keisuke Aoe
    Akira Koyama
    Naoyuki Komura
    Kenji Eguchi
    Supportive Care in Cancer, 2016, 24 : 3495 - 3505
  • [10] Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
    Takayama, Koichi
    Katakami, Nobuyuki
    Yokoyama, Takuma
    Atagi, Shinji
    Yoshimori, Kozo
    Kagamu, Hiroshi
    Saito, Hiroshi
    Takiguchi, Yuichi
    Aoe, Keisuke
    Koyama, Akira
    Komura, Naoyuki
    Eguchi, Kenji
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3495 - 3505
12345